Our Research Publications
Updated August 2025
Pagination
- Previous page
- Page 49
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production | Kozicky LK, Menzies SC, Hotte N, Madsen KL, Sly LM | 2019 | Eur J Immunol | View Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production | Researchers | Basic research |
Platelet rich plasma in treatment of musculoskeletal pathologies | Mehrabani D, Seghatchian J, Acker JP | 2019 | Transfus Apher Sci | View Platelet rich plasma in treatment of musculoskeletal pathologies | Researchers | Basic research |
Système Diego : l’anticorps anti-Dia | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Diego : l’anticorps anti-Dia | Health care providers | Benchmarking and standard setting |
Test-retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains | Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker J, Thabane L, Crowther MA, Iorio A | 2019 | Haemophilia | View Test-retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains | Researchers | Clinical research |
胎児および新生児(同種免疫 性)血小板減少症(FNAIT) 患者さんへの情報 |
International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View 胎児および新生児(同種免疫 性)血小板減少症(FNAIT) 患者さんへの情報 |
Other | Other |
Compliance with time-based deferrals for men who have sex with men | O'Brien SF, Osmond L, Fan W, Yi Q-L, Goldman M | 2019 | Transfusion | View Compliance with time-based deferrals for men who have sex with men | Researchers | MSM research |
Bacterial safety of blood components - a congress review of the ISBT transfusion-transmitted infectious diseases working party, bacterial subgroup | Ramirez-Arcos S, McDonald C, Deol P, Kreuger AL, Patel N, Pidcoke H, Prax M, Seltsam A, Stassinopoulos A, The ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | 2019 | ISBT Sci Ser | View Bacterial safety of blood components - a congress review of the ISBT transfusion-transmitted infectious diseases working party, bacterial subgroup | Researchers | Other |
Donor selection, donor testing and pathogen reduction | Goldman M, Drews S, Devine D | 2019 | Clinical Guide to Transfusion | View Donor selection, donor testing and pathogen reduction | Health care providers | Benchmarking and standard setting |
Striking the balance: protecting data privacy in research | Ward R | 2019 | Blood.ca website | View Striking the balance: protecting data privacy in research | Health care providers | Other |
The effect of tantalum incorporation on the physical and chemical properties of ternary silicon–calcium–phosphorous mesoporous bioactive glasses | Mendonca A, Rahman MS, Alhalawani A, Rodriguez O, Gallant RC, Ni H, Clarkin OM, Towler MR | 2019 | J Biomed Mater Res B Appl Biomater | View The effect of tantalum incorporation on the physical and chemical properties of ternary silicon–calcium–phosphorous mesoporous bioactive glasses | Researchers | Basic research |
Trends and outcomes in multicomponent blood transfusion: an 11-year cohort study of a large multisite academic center | Perelman I, Saidenberg E, Tinmouth A, Fergusson D | 2019 | Transfusion | View Trends and outcomes in multicomponent blood transfusion: an 11-year cohort study of a large multisite academic center | Researchers | Clinical research |
Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference? | Carcao MD, Chelle P, Clarke E, Kim L, Tiseo L, Morfini M, Hossain T, Rand ML, Brown C, Edginton AN, Lillicrap D, Iorio A, Blanchette VS | 2019 | J Thromb Haemost | View Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference? | Researchers | Clinical research |
Fractionated blood products and associated pathogen safety | Bigham M | 2019 | Clinical Guide to Transfusion | View Fractionated blood products and associated pathogen safety | Health care providers | Benchmarking and standard setting |
Major reductions in unnecessary aspartate aminotransferase and blood urea nitrogen tests with a quality improvement initiative | Strauss R, Cressman A, Cheung M, Weinerman A, Waldman S, Etchells E, Zahirieh A, Tartaro P, Tezmovitz J, Callum J | 2019 | BMJ Quality & Safety | View Major reductions in unnecessary aspartate aminotransferase and blood urea nitrogen tests with a quality improvement initiative | Health care providers | Clinical research |
Rapport de surveillance 2018 | O'Brien S | 2019 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Transfusion Camp: a prospective evaluation of a transfusion education program for multispecialty postgraduate trainees | Lin Y, Tilokee E, Chargé S, Alam A, Cserti-Gazdewich C, Lau W, Lee C, Lieberman L, Nixon P, Owens W, Pavenski K, Pendergrast J, Saidenberg E, Shehata N, Skeate R, Yi Q-L, Conrad D, Dudebout J, Hsia CC, Murphy M, Prokopchuk-Gauk O, Shah A, Solh Z, Trudeau J, Zeller MP, Callum J | 2019 | Transfusion | View Transfusion Camp: a prospective evaluation of a transfusion education program for multispecialty postgraduate trainees | Health care providers | Other |
Biofilm-associated accumulation-associated protein (Aap): A contributing factor to the predominant growth of Staphylococcus epidermidis in platelet concentrates | Alabdullatif M, Ramirez-Arcos S | 2019 | Vox Sang | View Biofilm-associated accumulation-associated protein (Aap): A contributing factor to the predominant growth of Staphylococcus epidermidis in platelet concentrates | Researchers | New or improved product or process |
Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department | Ramos JG, Zeller MP | 2019 | Hematology Am Soc Hematol Educ Program | View Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
Label-Free Analysis of Red Blood Cell Storage Lesions Using Imaging Flow Cytometry | Pinto RN, Sebastian JA, Parsons MJ, Chang TC, Turner TR, Acker JP, Kolios MC | 2019 | Cytom Part A | View Label-Free Analysis of Red Blood Cell Storage Lesions Using Imaging Flow Cytometry | Researchers | New or improved product or process |
Prevalence of Red Blood Cell Major Blood Group Antigens and Phenotypes among Omani Blood Donors | Al-Riyami AZ, Al-Marhoobi A, Al-Hosni S, Al Mahrooqi S, Schmidt M, O'Brien SF, Al-Khabori M | 2019 | Oman Med J | View Prevalence of Red Blood Cell Major Blood Group Antigens and Phenotypes among Omani Blood Donors | Researchers | Clinical research |
Système Rhésus : l’anticorps anti-Cw | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-Cw | Health care providers | Benchmarking and standard setting |
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Liem RI, Lanzkron S, T DC, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA | 2019 | Blood Adv | View American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Health care providers | Benchmarking and standard setting |
Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data | Shih AW, Apelseth TO, Cardigan R, Marks DC, Bégué S, Greinacher A, de Korte D, Seltsam A, Shaz BH, Wikman A, Barty RL, Heddle NM, Acker JP, The QMiP Investigators on behalf of the Biomedical Excellence for Safer Transfusion Collaborative | 2019 | Vox Sang | View Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data | Researchers | Benchmarking and standard setting |
Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Goldman M, Drews S, Devine D | 2019 | Guide de la pratique transfusionnelle | View Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
Drug-induced immune haemolytic anaemias | Branch DR | 2019 | ISBT Sci Ser | View Drug-induced immune haemolytic anaemias | Researchers | Basic research |
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee | Cohn CS, Allen ES, Cushing MM, Dunbar NM, Friedman DF, Goel R, Harm SK, Heddle N, Hopkins CK, Klapper E, Perumbeti A, Ramsey G, Raval JS, Schwartz J, Shaz BH, Spinella PC, Pagano MB | 2019 | Transfusion | View Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee | Researchers | Clinical research |
Modulating the T Lymphocyte Immune Response via Secretome Produced miRNA: From Tolerance Induction to the Enhancement of the Anticancer Response | Scott M, Wang D, Toyofuku W, Yang X | 2019 | Cells of the Immune System | View Modulating the T Lymphocyte Immune Response via Secretome Produced miRNA: From Tolerance Induction to the Enhancement of the Anticancer Response | Researchers | Basic research |
A retrospective study of the added value of parallel titers compared with serial titers | Lin Y, Cohen R, Buckstein J, Callum J, Lieberman L | 2019 | Transfusion | View A retrospective study of the added value of parallel titers compared with serial titers | Health care providers | Clinical research |
Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Scott AN, Buchan SA, Kwong JC, Drews SJ, Simmonds KA, Svenson LW | 2019 | BMJ Open | View Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Researchers | Clinical research |
Acquired Thrombocytopenia | Warkentin TE, Mithoowani S, Arnold DM | 2019 | Concise Guide to Hematology | View Acquired Thrombocytopenia | Other | Other |
Changing the deferral for men who have sex with men - an improved model to estimate HIV residual risk | Davison KL, Gregoire Y, Germain M, Custer B, O'Brien SF, Steele WR, Pillonel J, Seed CR | 2019 | Vox Sang | View Changing the deferral for men who have sex with men - an improved model to estimate HIV residual risk | Blood operators | New or improved product or process |
Ironing out frequent blood donation | Devine DV | 2019 | Lancet Haematol | View Ironing out frequent blood donation | Researchers | New or improved product or process |
Système Diego : l’anticorps anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Diego : l’anticorps anti-Wra | Health care providers | Benchmarking and standard setting |
Trombocitopenia Fetal Neonatal Aloimune: Informacao ao paciente | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Trombocitopenia Fetal Neonatal Aloimune: Informacao ao paciente | Other | Other |
Heparin-induced thrombocytopenia (Chap. 26). | Warkentin TE | 2019 | Consultative Hemostasis and Thrombosis, Fourth Edition | View Heparin-induced thrombocytopenia (Chap. 26). | Other | Benchmarking and standard setting |
Bonnes pratiques en matière de transfusion de plaquettes | Romans R | 2019 | Blood.ca website | View Bonnes pratiques en matière de transfusion de plaquettes | Health care providers | Benchmarking and standard setting |
Platelet clinical best practices | Romans R | 2019 | Blood.ca website | View Platelet clinical best practices | Health care providers | Benchmarking and standard setting |
Surveillance Report 2018 | O'Brien S | 2019 | Blood.ca website | View Surveillance Report 2018 | Health care providers | Benchmarking and standard setting |
Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Goldman M, Germain M, Gregoire Y, Vassallo RR, Kamel H, Bravo M, Irving DO, Di Angelantonio E, Steele WR, O'Brien SF, for the Biomedical Excellence for Safer Transfusion Collaborative (BEST) Investigators | 2019 | Transfusion | View Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Blood operators | New or improved product or process |
45 - Alloimmune Thrombocytopenia | Kaplan C, Bertrand G, Ni H | 2019 | Platelets (Fourth Edition) | View 45 - Alloimmune Thrombocytopenia | Researchers | New or improved product or process |
Translating red cell "omics" into new perspectives in transfusion medicine: mining the gems in the data mountains | Spitalnik SL, Devine DV | 2019 | Transfusion | View Translating red cell "omics" into new perspectives in transfusion medicine: mining the gems in the data mountains | Researchers | Other |
Gay and bisexual men’s views on reforming blood donation policy in Canada: a qualitative study | Grace D, Gaspar M, Lessard D, Klassen B, Brennan DJ, Adam BD, Jollimore J, Lachowsky NJ, Hart TA | 2019 | BMC Public Health | View Gay and bisexual men’s views on reforming blood donation policy in Canada: a qualitative study | Researchers | Other |
Management of iron deficiency | Ning S, Zeller MP | 2019 | Hematology Am Soc Hematol Educ Program | View Management of iron deficiency | Health care providers | Clinical research |
Réduction des agents pathogènes dans les produits de fractionnement | Bigham M | 2019 | Guide de la pratique transfusionnelle | View Réduction des agents pathogènes dans les produits de fractionnement | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Jenkins C | 2018 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls | Mannucci PM, Nobili A, Marchesini E, Oliovecchio E, Cortesi L, Coppola A, Santagostino E, Radossi P, Castaman G, Valdrè L, Santoro C, Tagliaferri A, Ettorre C, Zanon E, Barillari G, Cantori I, Caimi TM, Sottilotta G, Peyvandi F, Iorio A | 2018 | Haemophilia | View Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls | Health care providers | Clinical research |
Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Adams Z, Morris G, Campbell T, Mostert K, Dibdin N, Fearon M, Elmoazzen H, Mercer D, Young K, Allan D | 2018 | Biol Blood Marrow Transplant | View Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Blood operators | Clinical research |
Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review | Siegal DM, Manning N, Jackson Chornenki NL, Hillis CM, Heddle NM | 2018 | J Intensive Care Med | View Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review | Researchers | New or improved product or process |
Splenectomy for immune thrombocytopenia: down but not out | Chaturvedi S, Arnold DM, McCrae KR | 2018 | Blood | View Splenectomy for immune thrombocytopenia: down but not out | Health care providers | Clinical research |
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents | Xu XR, Yousef GM, Ni H | 2018 | Blood | View Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents | Health care providers | Clinical research |